Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ramon Varcoe MBBS, MS, FRACS, PhD, MMed (ClinEpi)

Prof. Ramon L. Varcoe MBBS, MS, FRACS, PhD, MMed (ClinEpi)

Associate Professor of Vascular Surgery, University of New South Wales and Prince of Wales Hospital, Sydney, Australia

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia,  and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is an Associate Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 120 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 200 individual occasions.


Disclosure: Abbott, Medtronic, Boston, Philips, Gore, Surmodics, R3, Intervene, Alucent, Vesteck, Cook, BD

Equity: Provision, EBR Systems, Vesteck